MedTrace Logo

Reading Performance in Patients With Acrysof IQ Vivity Versus Acrysof IQ

NCT05194657 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2022-01-18

No results posted yet for this study

Summary

Comparison of the visual function and reading performance between the Acrysof IQ Vivity IOL, an EDOF IOL, and the monofocal Acrysof IQ.

Conditions

  • Cataract

Interventions

DEVICE

enhanced depth of focus IOL

Acrysof IQ Vivity, enhanced depth of focus IOL

DEVICE

monofocal IOL

Acrysof IQ, monofocal IOL

Sponsors & Collaborators

  • Vienna Institute for Research in Ocular Surgery

    lead OTHER

Principal Investigators

  • Oliver Findl, MD · Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-03
Primary Completion
2023-01-03
Completion
2024-01-03

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05194657 on ClinicalTrials.gov